We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mycelx Technologies Corporation | LSE:MYXR | London | Ordinary Share | COM SHS USD0.025 (REG S) (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 40.00 | 60.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMYX TIDMMYXR
RNS Number : 5853G
MyCelx Technologies Corporation
30 May 2017
MYCELX Technologies Corporation
("MYCELX" or the "Company") (AIM: MYX)
30 May 2017
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). This inside information is now considered to be in the public domain.
Grant of Share Option to Chief Financial Officer
On 26 May 2017 Ms. Slayton was awarded the following options over the Company's common shares of US$0.025 each ("Common Shares") under the MYCELX Omnibus Performance Incentive Plan ("Plan"):
Hot Features
Premium
Name Number of Exercise Total number Total number
share options price of share of share options
granted options held as % of current
following issued share
this notification capital
Kimberly
Slayton 30,000 US$0.75* 130,000 0.69%
Ms. Slayton holds no Common Shares in the issued capital of the Company.
Grant of Share Option to Chief Business Development Officer
The Company further announces that Mark Mixon, Chief Business Development Officer, was granted an option on 26 May 2017 under the Plan over 35,000 Common Shares. The grant to Mr. Mixon was as follows:
Name Number of Exercise Total number Total number
share options price of share of share options
granted options held as % of current
following issued share
this notification capital
Mark Mixon 35,000 US$0.75* 300,204 1.60%
In addition, following this transaction, Mr. Mixon continues to be interested in 10,000 Common Shares, representing 0.05 per cent of the present issued capital of the Company, which he holds as a custodian.
Grant of Share Option to Chief Executive Officer
The Company further announces that Connie Mixon, Chief Executive Officer, was granted an option on 26 May 2017 under the Plan over 40,000 Common Shares. The grant to Ms. Mixon was as follows:
Name Number of Exercise Total number Total number
share options price of share of share options
granted options held as % of current
following issued share
this notification capital
Connie
Mixon 40,000 US$0.75* 203,017 1.08%
Following this award, Connie Mixon, Chief Executive Officer and spouse of Mr. Mixon is interested in an aggregate (including the interests of Mr. Mixon) of 991,211 Common Shares, representing 5.28 per cent of the present issued capital of the Company, and in options over an aggregate (including the interests of Mr. Mixon) of 503,221 Common Shares, representing 2.68 per cent of the present issued capital of the Company.
The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 shares held by or on behalf of Ms. Mixon's children.
The above grants formed part of wider grants of 205,000 options to employees across the Company, on the same date, representing 1.09% of the current issued share capital.
The share options granted on 26 May 2017 will vest as to 50% on 31 December 2017 and 50% on 31 December 2018, and must be exercised prior to the tenth anniversary of the date of grant, subject to the restrictions on dealing under the Company's share dealing code.
Following the above grants, a total of 1,192,042 share options have been granted to directors and employees and are currently outstanding, representing 6.35% of the issued share capital of 18,770,117 Common Shares. *Based on the closing mid-market price of the Company's Common Shares at 26 May 2017, and the closing US/GBP exchange rate at that date.
For further information please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Tel: +1 888 306 6843 Kim Slayton, CFO Cantor Fitzgerald Europe - NOMAD and Broker Andrew Craig Tel: +44 20 7894 7000 Richard Salmond Celicourt Communications Mark Antelme Tel: +44 20 7520 9266 Joanna Boon
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).
Notification of transactions of persons discharging managerial responsibility or connected persons
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -------------------------------------------------------------
a) Name Connie Mixon
--- ------------------------- ----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Director
--- ------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
--- ------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mycelx Technologies Corporation
--- ------------------------- ----------------------------------
b) LEI 213800UJZINIK2VD1G48
--- ------------------------- ----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description of
the financial Common shares of US$0.025
instrument, type
of instrument USU624551078
Identification
code
--- ------------------------- ----------------------------------
b) Nature of the Grant of share option to
transaction Connie Mixon under the Mycelx
Omnibus Performance Incentive
Plan
--- ------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
US$0.75 40,000
---------- ----------
--- ------------------------- ----------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
--- ------------------------- ----------------------------------
e) Date of the transaction 2017/05/26
--- ------------------------- ----------------------------------
f) Place of the transaction Grant of the options
occurred outside a trading
venue.
--------------------------------
--- ------------------------- ----------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -------------------------------------------------------------
a) Name Connie Mixon
--- ------------------------- ----------------------------------
2 Reason for the notification
--- -------------------------------------------------------------
a) Position/status Director
--- ------------------------- ----------------------------------
b) Initial notification Initial notification
/Amendment
--- ------------------------- ----------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -------------------------------------------------------------
a) Name Mycelx Technologies Corporation
--- ------------------------- ----------------------------------
b) LEI 213800UJZINIK2VD1G48
--- ------------------------- ----------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description of
the financial Common shares of US$0.025
instrument, type
of instrument USU624551078
Identification
code
--- ------------------------- ----------------------------------
b) Nature of the Grant of share option to
transaction spouse, Mark Mixon, under
the Mycelx Omnibus Performance
Incentive Plan
--- ------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
US$0.75 35,000
---------- ----------
--- ------------------------- ----------------------------------
d) Aggregated information
- Aggregated volume n/a
- Price n/a
--- ------------------------- ----------------------------------
e) Date of the transaction 2017/05/26
--- ------------------------- ----------------------------------
f) Place of the transaction Grant of the options
occurred outside a trading
venue.
--------------------------------
--- ------------------------- ----------------------------------
Notes to Editors
MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.
www.mycelx.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFLFETIIVID
(END) Dow Jones Newswires
May 30, 2017 08:19 ET (12:19 GMT)
1 Year Mycelx Technologies Chart |
1 Month Mycelx Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
